Global Cancer Biological Therapy Market 2018 Size, Development Status, Type and Application, Segmentation, Forecast by 2023

WiseGuyReports.com adds “Cancer Biological Therapy Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023”reports to its database.

Pune, India - January 12, 2018 /MarketersMedia/ —

Cancer Biological Therapy Market:

Executive Summary

Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. There are various types of biological therapies, which inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.

The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a CAGR of 4.7% during the forecasted period.  

The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.

On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, interferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.

On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023. 

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Players

The leading market players in the global cancer biological therapy market include Merck Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Bristol-Myers Squibb, Celgene, ELI Lilly and Company, EnGeneIC, and Pfizer

Study objectives

To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global cancer biological therapy market
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global cancer biological therapy market.
To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
To provide economical factors that influences the global cancer biological therapy market
To provide detailed analysis of the value chain and supply chain of the global cancer biological therapy market

Target Audience

Pharmaceutical Companies
Pharmaceutical Suppliers
Cancer Research Organizations
Potential Investors
Key Executive (CEO and COO) and Strategy Growth Manager
Reaserch Companies

For further information on this report, visit - https://www.wiseguyreports.com/enquiry/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Key Findings

North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016

The reports also covers regional analysis

North America
o US

o Canada

Europe
o Germany

o France

o U.K.

o Italy

o Spain

o Rest of Europe

Asia Pacific
o Japan

o China

o India

o Republic of Korea

o Rest of Asia-Pacific

Middle East & Africa
o Middle East

o Africa

Continuous…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1793685

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: Wise Guy Research Consultants Pvt Ltd
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349 (US); +44 208 133 9349 (UK)

Source URL: https://marketersmedia.com/global-cancer-biological-therapy-market-2018-size-development-status-type-and-application-segmentation-forecast-by-2023/286775

For more information, please visit https://www.wiseguyreports.com/reports/1793685-global-cancer-biological-therapy-analysis-forecast-2016-to-2023

Source: MarketersMedia

Release ID: 286775

Latest News

UK's May wins no-confidence vote by MPs unhappy over Brexit

Dec 13, 2018

LONDON — British Prime Minister Theresa May survived a political crisis over her Brexit deal Wednesday, winning a no-confidence vote by Conservative lawmakers that would have ended her leadership of party and country. But the margin of victory — 200 votes to 117 — leaves May a weakened leader who has lost the support of a big chunk of her party over her handling of Britain's exit from the European Union. It also came at a steep price as she promised not to run for re-election in 2022. Britain's Brexit problem, meanwhile, remains unsolved as May seeks changes to her...

The Latest: UK's May grateful for vote keeping her in office

Dec 13, 2018

LONDON — The Latest on political turmoil in Britain (all times local): 9:40 p.m. Prime Minister Theresa May says she is "grateful" for the support she received from Conservative Party lawmakers who voted to keep her as their leader. The prime minister acknowledged Wednesday after she survived a party confidence vote with a 200-117 tally that a substantial number of Conservatives voted against her. May says she will keep pursuing a deal on Britain's departure from the European Union. She said she will attend an EU summit on Thursday seeking more assurances and concessions from other European leaders. The goal...

Team Sky future in doubt after owner withdraws from cycling

Dec 13, 2018

LONDON — The future of the most successful cycling team of the last decade was put in doubt Wednesday when Sky announced its withdrawal from the sport following the European pay TV giant's takeover by American company Comcast. Team Sky, which had a rider win the Tour de France this year for the sixth time in seven races, will require new ownership if it is to continue competing — under a new name — from 2020. "We plan to be together in 2020 if at all possible," said Chris Froome, who has raced for Team Sky since its debut in...

US-China trade hopes help shore up global stock markets

Dec 13, 2018

LONDON — Global shares rose Wednesday amid hopes for progress in U.S.-China trade talks while U.K. markets took in stride the news that British Prime Minister Theresa May will face a no-confidence vote among her party's lawmakers later. KEEPING SCORE: In Europe, Germany's DAX was up 1.2 percent at 10,904 while the CAC 40 in France was 1.8 percent higher at 4,895. The FTSE 100 index of leading British shares rose 1.3 percent to 6,894. U.S. stocks were poised for a solid open too, with Dow futures and the broader S&P 500 futures up 1 percent. TRADE TALKS: Recent media...

The Latest: Trump says he could intervene in Huawei case

Dec 13, 2018

VANCOUVER, British Columbia — The latest on the arrest in Canada of Chinese tech executive Meng Wanzhou. (all times local): 4:25 p.m. President Donald Trump says he would consider intervening in the Justice Department's case against a top Chinese executive if it would be in the interest of U.S. national security and help forge a trade deal with China. Trump told Reuters in an interview Tuesday at the White House that if he thinks it would be good for what will "certainly be the largest trade deal ever made" he would intervene if necessary. A Canadian court granted bail on...

Financial Markets

Market Sanctum is one of the world’s leading news sources for the currency trading community. Our analysts report on the latest changes in the current market, providing in-depth analysis.

Contact us: sales[at]marketsanctum.com